{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:36:31Z","timestamp":1767144991802,"version":"build-2238731810"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31771010"],"award-info":[{"award-number":["31771010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672803"],"award-info":[{"award-number":["81672803"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.bbadis.2023.166964","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T04:32:33Z","timestamp":1700627553000},"page":"166964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Functional characterization of AF-04, an afucosylated anti-MARV GP antibody"],"prefix":"10.1016","volume":"1870","author":[{"given":"Min","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longlong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxia","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanqiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanchun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiannan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guojiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2023.166964_bb0005","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000149300","article-title":"Filoviridae: a taxonomic home for Marburg and Ebola viruses?","volume":"18","author":"Kiley","year":"1982","journal-title":"Intervirology"},{"key":"10.1016\/j.bbadis.2023.166964_bb0010","first-page":"308","article-title":"Outbreak of Marburg virus hemorrhagic fever--Angola, October 1, 2004-March 29, 2005","volume":"54","author":"CDC","year":"2005","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"Suppl. 2","key":"10.1016\/j.bbadis.2023.166964_bb0015","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1086\/520543","article-title":"Marburg hemorrhagic fever in Durba and Watsa, Democratic Republic of the Congo: clinical documentation, features of illness, and treatment","volume":"196","author":"Colebunders","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbadis.2023.166964_bb0020","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.3390\/v4101878","article-title":"Forty-five years of Marburg virus research","volume":"4","author":"Brauburger","year":"2012","journal-title":"Viruses"},{"issue":"Suppl. 7","key":"10.1016\/j.bbadis.2023.166964_bb0025","doi-asserted-by":"crossref","first-page":"S682","DOI":"10.1093\/infdis\/jiad345","article-title":"AAV-vectored expression of Marburg virus-neutralizing antibody MR191 provides complete protection from challenge in a guinea pig model","volume":"228","author":"Rghei","year":"2023","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbadis.2023.166964_bb0030","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3390\/pathogens11030374","article-title":"Development and structural analysis of antibody therapeutics for filoviruses","volume":"11","author":"Yu","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.bbadis.2023.166964_bb0035","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3390\/pathogens10091201","article-title":"Filovirus neutralising antibodies: mechanisms of action and therapeutic application","volume":"10","author":"Hargreaves","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.bbadis.2023.166964_bb0040","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.immuni.2020.01.001","article-title":"Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization","volume":"52","author":"Gilchuk","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.bbadis.2023.166964_bb0045","doi-asserted-by":"crossref","first-page":"S612","DOI":"10.1093\/infdis\/jiy285","article-title":"Development of clinical-stage human monoclonal antibodies that treat advanced Ebola virus disease in nonhuman primates","volume":"218","author":"Pascal","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbadis.2023.166964_bb0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature13777","article-title":"Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp","volume":"514","author":"Qiu","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2023.166964_bb0055","doi-asserted-by":"crossref","first-page":"8947","DOI":"10.3390\/ijms22168947","article-title":"The role of fc receptors on the effectiveness of therapeutic monoclonal antibodies","volume":"22","author":"Gogesch","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2023.166964_bb0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/imr.12365","article-title":"Structural analysis of fc\/Fc\u03b3R complexes: a blueprint for antibody design","volume":"268","author":"Caaveiro","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbadis.2023.166964_bb0065","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jim.2005.08.009","article-title":"IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides","volume":"306","author":"Niwa","year":"2005","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bbadis.2023.166964_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134949","article-title":"In vitro glycoengineering of IgG1 and its effect on fc receptor binding and ADCC activity","volume":"10","author":"Thomann","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.bbadis.2023.166964_bb0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/antib9040063","article-title":"Enhancing CDC and ADCC of CD19 antibodies by combining fc protein-engineering with fc Glyco-engineering","volume":"9","author":"Ro\u00dfkopf","year":"2020","journal-title":"Antibodies (Basel)"},{"key":"10.1016\/j.bbadis.2023.166964_bb0080","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.1074\/jbc.M009483200","article-title":"High resolution mapping of the binding site on human IgG1 for fc gamma RI, fc gamma RII, fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the fc gamma R","volume":"276","author":"Shields","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2023.166964_bb0085","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/19420862.2018.1466767","article-title":"The \"less-is-more\" in therapeutic antibodies: Afucosylated anti-cancer antibodies with enhanced antibody-dependent cellular cytotoxicity","volume":"10","author":"Pereira","year":"2018","journal-title":"MAbs"},{"key":"10.1016\/j.bbadis.2023.166964_bb0090","doi-asserted-by":"crossref","first-page":"26733","DOI":"10.1074\/jbc.M202069200","article-title":"Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity","volume":"277","author":"Shields","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2023.166964_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaq0891","article-title":"Mechanisms of inside-out signaling of the high-affinity IgG receptor Fc\u03b3RI","volume":"11","author":"Brandsma","year":"2018","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbadis.2023.166964_bb0100","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00796-21","article-title":"Enhanced ability of plant-derived PGT121 Glycovariants to eliminate HIV-1-infected cells","volume":"95","author":"Anand","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.bbadis.2023.166964_bb0105","doi-asserted-by":"crossref","first-page":"20690","DOI":"10.1073\/pnas.1108360108","article-title":"Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant","volume":"108","author":"Zeitlin","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2023.166964_bb0110","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/1078-0432.CCR-09-2697","article-title":"Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia\/lymphoma","volume":"16","author":"Ishii","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2023.166964_bb0115","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1073\/pnas.1402458111","article-title":"Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy","volume":"111","author":"Hiatt","year":"2014","journal-title":"PNAS"},{"key":"10.1016\/j.bbadis.2023.166964_bb0120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.chom.2018.12.004","article-title":"Development of a human antibody cocktail that deploys multiple functions to confer Pan-ebolavirus protection","volume":"25","author":"Wec","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bbadis.2023.166964_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0168-1702(92)90027-7","article-title":"Marburg virus, a filovirus: messenger RNAs, gene order, and regulatory elements of the replication cycle","volume":"24","author":"Feldmann","year":"1992","journal-title":"Virus Res."},{"key":"10.1016\/j.bbadis.2023.166964_bb0130","article-title":"A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus","volume":"2009","author":"Zhang","year":"2023","journal-title":"BioRxiv"},{"key":"10.1016\/j.bbadis.2023.166964_bb0135","doi-asserted-by":"crossref","first-page":"329ra333","DOI":"10.1126\/scitranslmed.aad9875","article-title":"Two-mAb cocktail protects macaques against the Makona variant of Ebola virus","volume":"8","author":"Qiu","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbadis.2023.166964_bb0140","article-title":"TIM-1 augments cellular entry of Ebola virus species and mutants, which is blocked by recombinant TIM-1 protein","volume":"10","author":"Zhang","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.bbadis.2023.166964_bb0145","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jim.2016.12.002","article-title":"Characterization of Fc\u03b3RIIIA effector cells used in in vitro ADCC bioassay: comparison of primary NK cells with engineered NK-92 and Jurkat T cells","volume":"441","author":"Hsieh","year":"2017","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bbadis.2023.166964_bb0150","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.mam.2012.12.004","article-title":"Roles of the nucleotide sugar transporters (SLC35 family) in health and disease","volume":"34","author":"Song","year":"2013","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.bbadis.2023.166964_bb0155","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/glycob\/cws064","article-title":"Identification of functional elements of the GDP-fucose transporter SLC35C1 using a novel Chinese hamster ovary mutant","volume":"22","author":"Zhang","year":"2012","journal-title":"Glycobiology"},{"key":"10.1016\/j.bbadis.2023.166964_bb0160","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1200\/JCO.2007.14.8957","article-title":"Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2\/neu-positive metastatic breast cancer","volume":"26","author":"Musolino","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2023.166964_bb0165","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3389\/fimmu.2019.00735","article-title":"Chronic HIV-1 infection alters the cellular distribution of Fc\u03b3RIIIa and the functional consequence of the Fc\u03b3RIIIa-F158V variant","volume":"10","author":"Phaahla","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2023.166964_bb0170","doi-asserted-by":"crossref","first-page":"8058","DOI":"10.1158\/0008-5472.CAN-09-0834","article-title":"Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high\/CD24low\/HER2low breast cancer stem cells","volume":"69","author":"Reim","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2023.166964_bb0175","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41577-021-00558-3","article-title":"Natural killer cells in antiviral immunity","volume":"22","author":"Bj\u00f6rkstr\u00f6m","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2023.166964_bb0180","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jim.2014.03.021","article-title":"Characterization of in vitro antibody-dependent cell-mediated cytotoxicity activity of therapeutic antibodies - impact of effector cells","volume":"407","author":"Chung","year":"2014","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bbadis.2023.166964_bb0185","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nri1632","article-title":"NFAT proteins: key regulators of T-cell development and function","volume":"5","author":"Macian","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2023.166964_bb0190","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jim.2014.07.010","article-title":"Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure fc effector function of therapeutic antibodies","volume":"414","author":"Cheng","year":"2014","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bbadis.2023.166964_bb0195","doi-asserted-by":"crossref","first-page":"3908289","DOI":"10.1155\/2017\/3908289","article-title":"A novel system for the quantification of the ADCC activity of therapeutic antibodies","volume":"2017","author":"Lallemand","year":"2017","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.bbadis.2023.166964_bb0200","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/s41590-018-0233-9","article-title":"Antibody-mediated protection against Ebola virus","volume":"19","author":"Saphire","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbadis.2023.166964_bb0205","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.chom.2018.07.009","article-title":"A role for fc function in therapeutic monoclonal antibody-mediated protection against Ebola virus","volume":"24","author":"Gunn","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bbadis.2023.166964_bb0210","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1126\/science.287.5458.1664","article-title":"Epitopes involved in antibody-mediated protection from Ebola virus","volume":"287","author":"Wilson","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2023.166964_bb0215","doi-asserted-by":"crossref","first-page":"18030","DOI":"10.1073\/pnas.1213709109","article-title":"Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques","volume":"109","author":"Olinger","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2023.166964_bb0220","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1467-7652.2008.00330.x","article-title":"Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure","volume":"6","author":"Strasser","year":"2008","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.bbadis.2023.166964_bb0225","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.chom.2020.03.025","article-title":"Non-neutralizing antibodies from a Marburg infection survivor mediate protection by fc-effector functions and by enhancing efficacy of other antibodies","volume":"27","author":"Ilinykh","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bbadis.2023.166964_bb0230","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1080\/19420862.2015.1045173","article-title":"Comparison of methods for the analysis of therapeutic immunoglobulin G fc-glycosylation profiles-part 2: mass spectrometric methods","volume":"7","author":"Reusch","year":"2015","journal-title":"MAbs"},{"key":"10.1016\/j.bbadis.2023.166964_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.929895","article-title":"Role of fc Core Fucosylation in the effector function of IgG1 antibodies","volume":"13","author":"Golay","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2023.166964_bb0240","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1021\/cb300130k","article-title":"Revisiting the role of glycosylation in the structure of human IgG fc","volume":"7","author":"Borrok","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bbadis.2023.166964_bb0245","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1182\/blood.V90.3.1109","article-title":"Fc gammaRIIIa-158V\/F polymorphism influences the binding of IgG by natural killer cell fc gammaRIIIa, independently of the fc gammaRIIIa-48L\/R\/H phenotype","volume":"90","author":"Koene","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2023.166964_bb0250","doi-asserted-by":"crossref","first-page":"14289","DOI":"10.1038\/s41598-020-71225-1","article-title":"Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies","volume":"10","author":"Steeds","year":"2020","journal-title":"Sci. Rep."}],"updated-by":[{"DOI":"10.1016\/j.bbadis.2024.167046","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000}}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443923003307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443923003307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T14:03:25Z","timestamp":1738418605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443923003307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0925443923003307"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166964","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional characterization of AF-04, an afucosylated anti-MARV GP antibody","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166964","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166964"}}